Document 3110 DOCN M94A3110 TI HIV 1 and HIV 2 in commercial blood donors of Gujarat. An epidemiological study. DT 9412 AU Bhattacharya RD; Khatri F; GAP, SIRMCE, B/02, Siddha Chakra Apt. Ahmedabad, India. SO Int Conf AIDS. 1994 Aug 7-12;10(1):151 (abstract no. PB0029). Unique Identifier : AIDSLINE ICA10/94369465 AB OBJECTIVES: To evaluate HIV 1 and HIV 2 infection trend in commercial Blood Donors of Gujarat. METHODS: 4 times per year, blood samples were collected from CBDs. The project is running since last 4 years. Each sample has been collected with pre-test counselling. 535 forms on KAP study have been evaluated. RESULTS: Since 1991, 535 CBDs have registered themselves with GAP, whose blood samples have been regularly tested for HIV at every 3 months interval. Karpas test kits has been used for screening and reconfirmation of the positive samples were done by ELISA test. 37 samples were found HIV positive, amongst these 4 were HIV 2 positive and 2 gave the positive reaction to both HIV 1 and 2. All the persons revealed their seropositivity at the first time when they came for the test excepting one. This person denied the sexual encounter earlier or in between the period. From the 37 seropositives, 20 admitted that they had visited CSW but rest 17 denied such encounter. CONCLUSION: None of the HIV 2 positives have ever visited CSW and all of them are of Blood Group A. The question is whether HIV 2 transmission is more potential through unsterilized equipments? Two person showed both positive reaction for HIV 1 and 2. It is to be recognised that HIV 2 has already been seen in the community of blood donors in India and if it is true that the blood donors did not visit the CSW yet they are positive, then the infection might have spread to them through the unsterilized equipments used at the blood tapping centres. And based on this the percentage of such infection rate is around 45%. DE *Blood Donors Human HIV Seropositivity/*EPIDEMIOLOGY *HIV-1 *HIV-2 India/EPIDEMIOLOGY Registries MEETING ABSTRACT SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).